Why we invested: Camena Bioscience
Earlier this year Mercia Ventures’ Lee Lindley and Marina Fuentes led a $10m investment into Camena Bioscience from Mercia Ventures. Camena have developed a ground-breaking, proprietary DNA synthesis platform which we think will revolutionise the synthetic DNA market, helping to catalyse the development and advancement of precision medicines for patients worldwide. Read about why Mercia